Publications by authors named "Nooshin Jalili"
Background: Knee osteoarthritis (OA) is one of the major causes of dysfunction that reduces patients' quality of life. The aim of current study was to investigate the effectiveness of muscle strengthening exercises on the clinical outcomes of patients with knee OA.
Methods: We conducted a single-blind clinical trial on 96 patients with mild to moderate knee osteoarthritis.
Red cell distribution width, a predictive factor in immunocompromised patients with COVID-19: A comparison retrospective study between cancer and kidney transplant patients.
Eur J Transl Myol
June 2022
We aimed to review the records of cancer and kidney transplant patients of out of 1135 COVID-19 patients, who were referred to our hospital (Valiasr) in Zanjan, from March 16th, 2020, to June 11th, 2020. This was single-center, historical cohort study. Patients were divided into different subgroups and compared of disease outcomes.
View Article and Find Full Text PDFObjectives: Herein, disease activity score 28 (DAS 28) was compared between patients with rheumatoid arthritis (RA) receiving the Mediterranean dietary pattern (MD) and low-fat diet. . Overweight and obese RA patients aged 15-75 y participated in this randomized feeding trial.
View Article and Find Full Text PDFObjectives: Knee osteoarthritis is a common global problem, especially in overweight and obese people. It is not clear that weight loss is a factor for pain reduction in these patients or dietary components are important. Herein, we compared the effects of Mediterranean (MD) and low-fat diet on pain, stiffness, and physical function in patients with knee osteoarthritis.
View Article and Find Full Text PDFArticle Synopsis
- - The study investigated the effectiveness of methylprednisolone, an immunosuppressive treatment, in improving clinical outcomes for severe COVID-19 patients during hospitalization in Iran.
- - A randomized controlled trial with 68 patients found that those treated with methylprednisolone had a significantly higher improvement rate (94.1%) and lower mortality (5.9%) compared to those receiving standard care alone (57.1% improvement and 42.9% mortality).
- - The findings suggest that administering methylprednisolone could enhance survival and reduce the severity of COVID-19 symptoms in hospitalized patients during the illness's early respiratory phase.